MedTrace Logo

Luminopia One Pilot Study

NCT02782117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2020-07-09

No results posted yet for this study

Summary

A single-arm, multi-center, open-label pilot study to evaluate the feasibility, safety, and efficacy of the Luminopia One digital therapeutic in improving visual acuity in a pediatric amblyopia population.

Conditions

  • Amblyopia

Interventions

DEVICE

Luminopia One

Luminopia One is a digital therapeutic that allows patients to watch videos with therapeutic modifications applied.

Sponsors & Collaborators

Principal Investigators

  • David Hunter, MD PhD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2019-02-06
Completion
2019-02-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782117 on ClinicalTrials.gov